140 related articles for article (PubMed ID: 1672097)
1. Monoclonal nature of transient abnormal myelopoiesis in Down's syndrome.
Kurahashi H; Hara J; Yumura-Yagi K; Murayama N; Inoue M; Ishihara S; Tawa A; Okada S; Kawa-Ha K
Blood; 1991 Mar; 77(6):1161-3. PubMed ID: 1672097
[TBL] [Abstract][Full Text] [Related]
2. Clonal studies in the myelodysplastic syndrome using X-linked restriction fragment length polymorphisms.
Tefferi A; Thibodeau SN; Solberg LA
Blood; 1990 May; 75(9):1770-3. PubMed ID: 1970487
[TBL] [Abstract][Full Text] [Related]
3. Transient abnormal myelopoiesis in Down's syndrome.
Kurahashi H; Hara J; Yumura-Yagi K; Tawa A; Kawa-Ha K
Leuk Lymphoma; 1992 Dec; 8(6):465-75. PubMed ID: 1297480
[TBL] [Abstract][Full Text] [Related]
4. Clonal analysis of transient myeloproliferative disorder in Down's syndrome.
Miyashita T; Asada M; Fujimoto J; Inaba T; Takihara Y; Sugita K; Bessho F; Furukawa T; Mizutani S
Leukemia; 1991 Jan; 5(1):56-9. PubMed ID: 1825681
[TBL] [Abstract][Full Text] [Related]
5. Additional chromosome abnormalities in transient abnormal myelopoiesis in Down's syndrome patients.
Kounami S; Aoyagi N; Tsuno H; Suzuki H; Kitano N; Koike M
Acta Haematol; 1997; 98(2):109-12. PubMed ID: 9286308
[TBL] [Abstract][Full Text] [Related]
6. Clonal involvement of granulocytes and monocytes, but not of T and B lymphocytes and natural killer cells in patients with myelodysplasia: analysis by X-linked restriction fragment length polymorphisms and polymerase chain reaction of the phosphoglycerate kinase gene.
van Kamp H; Fibbe WE; Jansen RP; van der Keur M; de Graaff E; Willemze R; Landegent JE
Blood; 1992 Oct; 80(7):1774-80. PubMed ID: 1356510
[TBL] [Abstract][Full Text] [Related]
7. Myeloproliferative disorders: usefulness of X-linked probes in diagnosis.
Taylor KM; Shetta M; Talpaz M; Kantarjian HM; Hardikar S; Chinault AC; McCredie KB; Spitzer G
Leukemia; 1989 Jun; 3(6):419-22. PubMed ID: 2566725
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the blast cell population in two neonates with Down's syndrome and transient myeloproliferative disorder.
Coulombel L; Derycke M; Villeval JL; Leonard C; Breton-Gorius J; Vial M; Bourgeois P; Tchernia G
Br J Haematol; 1987 May; 66(1):69-76. PubMed ID: 2954579
[TBL] [Abstract][Full Text] [Related]
9. Transient myeloproliferative disorder in a Down's neonate with rearranged T-cell receptor beta gene and evidence of in vivo maturation demonstrated by dual-colour flow cytometric DNA ploidy analysis.
Kwong YL; Cheng G; Tang TS; Robertson EP; Lee CP; Chan LC
Leukemia; 1993 Oct; 7(10):1667-71. PubMed ID: 8412331
[TBL] [Abstract][Full Text] [Related]
10. Molecular genetic approach to the analysis of clonal proliferation in hematologic disorders.
Morita K; Tsukamoto N; Karasawa M; Omine M
Nihon Ketsueki Gakkai Zasshi; 1989 Dec; 52(8):1414-22. PubMed ID: 2576494
[TBL] [Abstract][Full Text] [Related]
11. Clonal analysis using recombinant DNA probes from the X-chromosome.
Vogelstein B; Fearon ER; Hamilton SR; Preisinger AC; Willard HF; Michelson AM; Riggs AD; Orkin SH
Cancer Res; 1987 Sep; 47(18):4806-13. PubMed ID: 2887283
[TBL] [Abstract][Full Text] [Related]
12. Unusual diffuse liver fibrosis accompanying transient myeloproliferative disorder in Down's syndrome: a report of four autopsy cases and proposal of a hypothesis.
Miyauchi J; Ito Y; Kawano T; Tsunematsu Y; Shimizu K
Blood; 1992 Sep; 80(6):1521-7. PubMed ID: 1387814
[TBL] [Abstract][Full Text] [Related]
13. Clonal analysis of chronic myeloproliferative disorders using X-linked DNA polymorphisms.
Anger B; Janssen JW; Schrezenmeier H; Hehlmann R; Heimpel H; Bartram CR
Leukemia; 1990 Apr; 4(4):258-61. PubMed ID: 1973205
[TBL] [Abstract][Full Text] [Related]
14. Transient abnormal myelopoiesis in Down's syndrome neonates.
Kwong YL
Am J Pediatr Hematol Oncol; 1994 Nov; 16(4):387-8. PubMed ID: 7978064
[No Abstract] [Full Text] [Related]
15. Ultrastructural and ultracytochemical differences between transient myeloproliferative disorder and megakaryoblastic leukaemia in Down's syndrome.
Eguchi M; Sakaibara H; Suda J; Ozawa T; Hayashi Y; Sato T; Kojima S; Furukawa T
Br J Haematol; 1989 Nov; 73(3):315-22. PubMed ID: 2532535
[TBL] [Abstract][Full Text] [Related]
16. Expression of megakaryocytic and myeloid markers in blasts of transient abnormal myelopoiesis in a stillbirth with Down syndrome: report of histopathological findings of an autopsy case.
Ishigaki H; Miyauchi J; Yokoe A; Nakayama M; Yanagi T; Taga T; Ohta S; Itoh Y; Ogasawara K
Hum Pathol; 2011 Jan; 42(1):141-5. PubMed ID: 20970166
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in the understanding of transient abnormal myelopoiesis in Down syndrome.
Watanabe K
Pediatr Int; 2019 Mar; 61(3):222-229. PubMed ID: 30593694
[TBL] [Abstract][Full Text] [Related]
18. [Transitory abnormal myelopoiesis of the monoblastic form in a newborn infant with Down's syndrome and liver cirrhosis].
Urano Y; Kondo M; Hayashi Y; Wakuya J; Nakata T; Tanaka K; Seo A
Ann Pathol; 1983 Dec; 3(4):337-9. PubMed ID: 6230084
[TBL] [Abstract][Full Text] [Related]
19. In vivo effects of granulocyte-macrophage colony-stimulating factor and interleukin-3 on clonal and non-clonal cell populations in patients with clonal hematopoietic disorders.
Ganser A; Janssen JW; Ottmann OG; Seipelt G; Eder M; Becher R; Lindermann A; Herrmann F; Schulz G; Mertelsmann R
Leukemia; 1991 Jun; 5(6):487-92. PubMed ID: 1676079
[TBL] [Abstract][Full Text] [Related]
20. Assessment of X-chromosome inactivation patterns using the hypervariable probe M27 beta in normal hemopoietic cells and acute myeloid leukemic blasts.
Gale RE; Wheadon H; Linch DC
Leukemia; 1992 Jul; 6(7):649-55. PubMed ID: 1352560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
